FDA Inspection 862134 — Glaxosmithkline ConsumerHealthcare Holdings LLC DBA HALEON GROUP
The FDA completed an inspection of Glaxosmithkline ConsumerHealthcare Holdings LLC DBA HALEON GROUP on January 9, 2014 in Carlisle, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Food/Cosmetics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- January 9, 2014
- Fiscal Year
- 2014
- Product Type
- Food/Cosmetics
- Project Area
- Food Composition, Standards, Labeling and Econ
- Location
- Carlisle, PA (United States)